{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T17:26:36Z","timestamp":1694712396456},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1097\/pas.0b013e31815d6305","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T14:01:21Z","timestamp":1236261681000},"page":"928-935","source":"Crossref","is-referenced-by-count":9,"title":["Quantitation of the JAK2 V617F Mutation in Microdissected Bone Marrow Trephines: Equal Mutational Load in Myeloid Lineages and Rare Involvement of Lymphoid Cells"],"prefix":"10.1097","volume":"32","author":[{"given":"Marcus","family":"Kremer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Horn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ina","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Dechow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Gattenloehner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leticia","family":"Quintanilla-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Falko","family":"Fend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-16-20210131","first-page":"258","article-title":"Clonal analysis of chronic myeloproliferative disorders using X-linked DNA polymorphisms","volume":"4","author":"Anger","year":"1990","journal-title":"Leukemia"},{"key":"R2-16-20210131","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"R3-16-20210131","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1182\/blood-2005-12-4852","article-title":"Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders","volume":"108","author":"Bellanne-Chantelot","year":"2006","journal-title":"Blood"},{"key":"R4-16-20210131","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/sj.leu.2404649","article-title":"A higher JAK2 V617F-mutated clone is observed in platelets than in granulocytes from essential thrombocythemia patients, but not in patients with polycythemia vera and primary myelofibrosis","volume":"21","author":"Bellosillo","year":"2007","journal-title":"Leukemia"},{"key":"R5-16-20210131","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3324\/haematol.10527","article-title":"B-, T-, and NK-cell lineage involvement in JAK2V617F-positive patients with idiopathic myelofibrosis","volume":"92","author":"Bogani","year":"2007","journal-title":"Haematologica"},{"key":"R6-16-20210131","first-page":"658","article-title":"Evidence for pluripotent stem cell origin of idiopathic myelofibrosis: clonal analysis of a case characterized by a N-ras gene mutation","volume":"2","author":"Buschle","year":"1988","journal-title":"Leukemia"},{"key":"R7-16-20210131","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/S0140-6736(05)67785-9","article-title":"Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study","volume":"366","author":"Campbell","year":"2005","journal-title":"Lancet"},{"key":"R8-16-20210131","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1046\/j.1365-2141.1997.1933010.x","article-title":"Clonal haemopoiesis in normal elderly women: implications for the myeloproliferative disorders and myelodysplastic syndromes","volume":"97","author":"Champion","year":"1997","journal-title":"Br J Haematol"},{"key":"R9-16-20210131","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2353\/jmoldx.2007.060133","article-title":"Amplification refractory mutation system, a highly sensitive and simple polymerase chain reaction assay, for the detection of JAK2 V617F mutation in chronic myeloproliferative disorders","volume":"9","author":"Chen","year":"2007","journal-title":"J Mol Diagn"},{"key":"R10-16-20210131","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1007\/s00018-006-6272-7","article-title":"Oncogenic mechanisms in myeloproliferative disorders","volume":"63","author":"Delhommeau","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"R11-16-20210131","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1182\/blood-2006-03-007146","article-title":"Evidence that the JAK2 G1849T (V617F) mutation occurs in a lymphomyeloid progenitor in polycythemia vera and idiopathic myelofibrosis","volume":"109","author":"Delhommeau","year":"2007","journal-title":"Blood"},{"key":"R12-16-20210131","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s00428-005-0069-1","article-title":"Ancillary techniques in bone marrow pathology: molecular diagnostics on bone marrow trephine biopsies","volume":"447","author":"Fend","year":"2005","journal-title":"Virchows Arch"},{"key":"R13-16-20210131","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1182\/blood.V83.4.931.931","article-title":"Clonality and X-inactivation patterns in hematopoietic cell populations detected by the highly informative M27 beta DNA probe","volume":"83","author":"Fey","year":"1994","journal-title":"Blood"},{"key":"R14-16-20210131","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1172\/JCI109193","article-title":"Chronic myelocytic leukemia. Origin of some lymphocytes from leukemic stem cells","volume":"62","author":"Fialkow","year":"1978","journal-title":"J Clin Invest"},{"key":"R15-16-20210131","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1038\/sj.leu.2404341","article-title":"JAK2 V617F mutation analysis in different myeloid lineages (granulocytes, platelets, CFU-MK, BFU-E and CFU-GM) in essential thrombocythemia patients","volume":"20","author":"Florensa","year":"2006","journal-title":"Leukemia"},{"key":"R16-16-20210131","doi-asserted-by":"crossref","first-page":"242","DOI":"10.2353\/jmoldx.2007.060125","article-title":"Quantitative determination of JAK2 V617F by TaqMan: an absolute measure of averaged copies per cell that may be associated with the different types of myeloproliferative disorders","volume":"9","author":"Hammond","year":"2007","journal-title":"J Mol Diagn"},{"key":"R17-16-20210131","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2353\/jmoldx.2006.050128","article-title":"Detection of the activating JAK2 V617F mutation in paraffin-embedded trephine bone marrow biopsies of patients with chronic myeloproliferative diseases","volume":"8","author":"Horn","year":"2006","journal-title":"J Mol Diagn"},{"key":"R18-16-20210131","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.0902-4441.2006.t01-1-EJH2940.x","article-title":"B-CLL developing in a patient with PV is not affected by V617F mutation of the Janus kinase 2","volume":"77","author":"Hussein","year":"2006","journal-title":"Eur J Haematol"},{"key":"R19-16-20210131","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00277-007-0252-3","article-title":"Different involvement of the megakaryocytic lineage by the JAK2(V617F) mutation in polycythemia vera, essential thrombocythemia and chronic idiopathic myelofibrosis","volume":"86","author":"Hussein","year":"2007","journal-title":"Ann Hematol"},{"key":"R20-16-20210131","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1182\/blood-2006-04-017392","article-title":"Involvement of various hematopoietic-cell lineages by the JAK2V617F mutation in polycythemia vera","volume":"108","author":"Ishii","year":"2006","journal-title":"Blood"},{"key":"R21-16-20210131","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.molmed.2005.10.003","article-title":"A JAK2 mutation in myeloproliferative disorders: pathogenesis and therapeutic and scientific prospects","volume":"11","author":"James","year":"2005","journal-title":"Trends Mol Med"},{"key":"R22-16-20210131","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"R23-16-20210131","doi-asserted-by":"crossref","first-page":"6224","DOI":"10.1073\/pnas.0601462103","article-title":"The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation","volume":"103","author":"Jamieson","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R24-16-20210131","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1182\/blood-2005-03-1320","article-title":"Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders","volume":"106","author":"Jones","year":"2005","journal-title":"Blood"},{"key":"R25-16-20210131","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1182\/blood-2005-03-1287","article-title":"On the molecular origins of the chronic myeloproliferative disorders: it all makes sense","volume":"105","author":"Kaushansky","year":"2005","journal-title":"Blood"},{"key":"R26-16-20210131","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/sj.leu.2404214","article-title":"Essential thrombocythemias without V617F JAK2 mutation are clonal hematopoietic stem cell disorders","volume":"20","author":"Kiladjian","year":"2006","journal-title":"Leukemia"},{"key":"R27-16-20210131","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0301-472X(01)00789-5","article-title":"Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera","volume":"30","author":"Kralovics","year":"2002","journal-title":"Exp Hematol"},{"key":"R28-16-20210131","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"key":"R29-16-20210131","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1053\/hupa.2000.8445","article-title":"PCR analysis of IgH-gene rearrangements in small lymphoid infiltrates microdissected from sections of paraffin-embedded bone marrow specimens","volume":"31","author":"Kremer","year":"2000","journal-title":"Hum Pathol"},{"key":"R30-16-20210131","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/01.LAB.0000050762.61660.27","article-title":"Discordant bone marrow involvement in diffuse large B-cell lymphoma: comparative molecular analysis reveals a heterogeneous group of disorders","volume":"83","author":"Kremer","year":"2003","journal-title":"Lab Invest"},{"key":"R31-16-20210131","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1365-2141.2007.06497.x","article-title":"The JAK2 V617F mutation involves B- and T-lymphocyte lineages in a subgroup of patients with Philadelphia-chromosome negative chronic myeloproliferative disorders","volume":"136","author":"Larsen","year":"2007","journal-title":"Br J Haematol"},{"key":"R32-16-20210131","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1365-2141.2005.05682.x","article-title":"Mutation studies in CD3+, CD19+ and CD34+ cell fractions in myeloproliferative disorders with homozygous JAK2(V617F) in granulocytes","volume":"130","author":"Lasho","year":"2005","journal-title":"Br J Haematol"},{"key":"R33-16-20210131","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1182\/blood-2005-05-1898","article-title":"The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia","volume":"106","author":"Levine","year":"2005","journal-title":"Blood"},{"key":"R34-16-20210131","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"R35-16-20210131","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1182\/blood-2006-09-045963","article-title":"Novel activating JAK2 mutation in a patient with Down syndrome and B-cell precursor acute lymphoblastic leukemia","volume":"109","author":"Malinge","year":"2007","journal-title":"Blood"},{"key":"R36-16-20210131","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/287049a0","article-title":"Involvement of the B-lymphoid system in chronic myelogenous leukaemia","volume":"287","author":"Martin","year":"1980","journal-title":"Nature"},{"key":"R37-16-20210131","first-page":"173","article-title":"A simplified method of detection of clonal rearrangements of the T-cell receptor gamma chain gene","volume":"1","author":"McCarthy","year":"1992","journal-title":"Diagn Mol Pathol"},{"key":"R38-16-20210131","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1182\/blood-2005-09-3826","article-title":"Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders","volume":"107","author":"Passamonti","year":"2006","journal-title":"Blood"},{"key":"R39-16-20210131","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1182\/blood-2002-07-2341","article-title":"Both B and T lymphocytes may be clonally involved in myelofibrosis with myeloid metaplasia","volume":"101","author":"Reeder","year":"2003","journal-title":"Blood"},{"key":"R41-16-20210131","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/0046-8177(94)90084-1","article-title":"Optimal primer selection for clonality assessment by polymerase chain reaction analysis. Low grade B-cell lymphoproliferative disorders of nonfollicular center cells","volume":"25","author":"Segal","year":"1994","journal-title":"Hum Pathol"},{"key":"R42-16-20210131","doi-asserted-by":"crossref","first-page":"41893","DOI":"10.1074\/jbc.C500358200","article-title":"JAK1 and Tyk2 activation by the homologous polycythemia vera JAK2 V617F mutation: cross-talk with IGF1 receptor","volume":"280","author":"Staerk","year":"2005","journal-title":"J Biol Chem"},{"key":"R43-16-20210131","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4161\/cc.6.5.3919","article-title":"Oncogenes in myeloproliferative disorders","volume":"6","author":"Tefferi","year":"2007","journal-title":"Cell Cycle"},{"key":"R45-16-20210131","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","article-title":"The World Health Organization (WHO) classification of the myeloid neoplasms","volume":"100","author":"Vardiman","year":"2002","journal-title":"Blood"},{"key":"R46-16-20210131","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2144\/97231pf01","article-title":"Fluorescence imaging in human identity testing","volume":"23","author":"Worley","year":"1997","journal-title":"Biotechniques"},{"key":"R47-16-20210131","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/ajh.20663","article-title":"JAK2V617F mutation can occur exclusively in the erythroid lineage and be absent in granulocytes and progenitor cells in classic myeloproliferative disorders","volume":"81","author":"Zehentner","year":"2006","journal-title":"Am J Hematol"},{"key":"R48-16-20210131","doi-asserted-by":"crossref","first-page":"22788","DOI":"10.1074\/jbc.C500138200","article-title":"Identification of an acquired JAK2 mutation in polycythemia vera","volume":"280","author":"Zhao","year":"2005","journal-title":"J Biol Chem"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00000478-200806000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:02:35Z","timestamp":1618038155000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-200806000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0b013e31815d6305","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}